First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 100.0% of the 100,000 shares held after it.
1 other insider bought within 30 days.
Insider activity: Chief Executive Officer FIRESTONE LAWRENCE bought about $17.0K of XXII on Jan 4, 2024, the largest insider purchase at the company since 2021; 1 other insider bought within 30 days.
Nobody has filed for crossing 5%. That is a fact, not missing data.
XXII planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Lawrence DFirestone
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$939.7K
$622.1K
$565.1K
n/a
n/a
2022
$4.0M
$1.5M
$888.1K
-58%
n/a
2021
$2.5M
$2.8M
$1.3M
+40%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$14.5M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM XXII
FY Dec 2025
$17.6M
FY Dec 2024
$24.4M
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$2.9M
Mar 2026
$4.1M
Dec 2025
$3.5M
Sep 2025
$4.0M
Jun 2025
$4.1M
Mar 2025
$6.0M
Dec 2024
$4.0M
Sep 2024
$5.9M
At each fiscal year end
Single quarter
Net margin, TTM
-27.0%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM XXII
FY Dec 2025
-28.7%
FY Dec 2024
-62.2%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
-116.8%
Mar 2026
-79.4%
Dec 2025
-79.4%
Sep 2025
+136.8%
Jun 2025
-83.4%
Mar 2025
-72.7%
Dec 2024
-113.3%
Sep 2024
-63.2%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$8.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM XXII
FY Dec 2025
-$7.8M
FY Dec 2024
-$14.5M
FY Dec 2023
-$59.6M
FY Dec 2022
-$55.4M
FY Dec 2021
-$23.6M
Jun 2026
-$4.3M
Mar 2026
-$3.1M
Dec 2025
$2.7M
Sep 2025
-$4.0M
Jun 2025
-$3.5M
Mar 2025
-$3.0M
Dec 2024
-$4.4M
Sep 2024
-$3.0M
At each fiscal year end
Single quarter
Debt to equity
0.04x
LongTermDebt as filed 2025-12-31 (6 months older than the period end) (includes the current portion); equity 2026-06-30
Debt to equity XXII
FY Dec 2025
0.04x
FY Dec 2024
1.66x
FY Dec 2023
n/a
FY Dec 2022
0.04x
FY Dec 2021
n/a
Jun 2026
0.04x
Mar 2026
0.03x
Dec 2025
0.04x
Sep 2025
0.18x
Jun 2025
0.57x
Mar 2025
1.08x
Dec 2024
1.66x
Sep 2024
2.02x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-11.81x
TTM operating cash flow over LongTermDebt as filed 2025-12-31 (6 months older than the period end) (includes the current portion)
Cash flow to debt XXII
FY Dec 2025
-10.91x
FY Dec 2024
-2.15x
FY Dec 2023
-3.95x
FY Dec 2022
-13.23x
FY Dec 2021
n/a
Jun 2026
-11.81x
Mar 2026
-11.09x
Dec 2025
-10.91x
Sep 2025
-4.62x
Jun 2025
-4.30x
Mar 2025
-3.83x
Dec 2024
-2.15x
Sep 2024
-2.10x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-32.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity XXII
FY Dec 2025
-51.1%
FY Dec 2024
n/a
FY Dec 2023
-321.5%
FY Dec 2022
n/a
FY Dec 2021
-59.2%
Jun 2026
-32.4%
Mar 2026
-32.1%
Dec 2025
-51.1%
Sep 2025
-62.3%
Jun 2025
-686.5%
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
-462.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-16.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets XXII
FY Dec 2025
-20.8%
FY Dec 2024
-61.7%
FY Dec 2023
-198.1%
FY Dec 2022
n/a
FY Dec 2021
-51.1%
Jun 2026
-16.2%
Mar 2026
-15.4%
Dec 2025
-20.8%
Sep 2025
-23.2%
Jun 2025
-69.1%
Mar 2025
-59.7%
Dec 2024
-61.7%
Sep 2024
-88.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital XXII
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-92.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed XXII
FY Dec 2025
-73.5%
FY Dec 2024
-196.8%
FY Dec 2023
-86.3%
FY Dec 2022
n/a
FY Dec 2021
-50.8%
Jun 2026
-92.5%
Mar 2026
-87.6%
Dec 2025
-73.5%
Sep 2025
-76.6%
Jun 2025
-173.5%
Mar 2025
-547.6%
Dec 2024
-196.8%
Sep 2024
-133.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
P/E, trailing XXII
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
-$5.3M
market value at close 2026-10-27 on 2026-08-14 shares, plus LongTermDebt as filed 2025-12-31 (6 months older than the period end) (includes the current portion), minus cash 2026-06-30
Enterprise value XXII
FY Dec 2025
$1.6B
FY Dec 2024
$1.7T
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$12.7M
Mar 2026
$20.4M
Dec 2025
$1.6B
Sep 2025
$1.9B
Jun 2025
$26.0B
Mar 2025
$23.5B
Dec 2024
$1.7T
Sep 2024
$1.9T
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-11,677%
TTM free cash flow over market value at close 2026-10-27
FCF yield XXII
FY Dec 2025
-0.5%
FY Dec 2024
-0.0%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
-48.5%
Mar 2026
-27.1%
Dec 2025
-0.5%
Sep 2025
-0.8%
Jun 2025
-0.1%
Mar 2025
-0.1%
Dec 2024
-0.0%
Sep 2024
-0.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
PEG, trailing XXII
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
XXII ranks highest on risk and compliance (64th percentile) and financial health (39th), and lowest on growth (6th), among Consumer Goods peers.
Profitability
15
Inputs
Return on equity-32.4% · 16 pct, sector of 105
Return on assets-16.2% · 21 pct, sector of 124
Return on invested capitaltax provision or pre-tax income not filed for the four quarters
Return on capital employed-92.5% · 8 pct, sector of 108
Financial health
39
Inputs
Debt to equity0.04x · 74 pct, sector of 112
Cash flow to debt-11.81x · 3 pct, sector of 96
Growth
6
Inputs
Revenue growth, YoY-27.9% · 6 pct, sector of 145
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
64
Inputs
Short interest, % of float+7.5% · 33 pct, sector of 159
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+3.5% · 95 pct, sector of 111
3 not measured: Insider conviction, Institutional and government, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.